Close Menu

NEW YORK (360Dx) – Vermillion said today that its subsidiary Aspira Labs has entered an in-network contract agreement for its OVA1 ovarian cancer test with TriCare's HealthNet Federal Services.

Tricare is the healthcare program for active and returned military service members and their families. With the agreement, which is effective January 1, 2018, OVA1 is covered through TriCare for more than 9.4 million lives, Vermillion said.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.